Send to a Friend Font Size: Increase Decrease

RDY and TEVA Related Headlines

Mar 9, 2026 10:53AM FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'

RDY and TEVA Related Press Releases

RDY and TEVA Related SEC Filings